Skip to main content

letter

. 1984 Oct;18(4):648–650. doi: 10.1111/j.1365-2125.1984.tb02523.x

Nifedipine and endocrine status in diabetic patients.

E Abadie, C Gauville, C Brisson

PMCID: PMC1463624 PMID: 6487511

648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Frantz A. G., Rabkin M. T. Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab. 1965 Nov;25(11):1470–1480. doi: 10.1210/jcem-25-11-1470. [DOI] [PubMed] [Google Scholar]
Gerich J. E. Role of growth hormone in diabetes mellitus. N Engl J Med. 1984 Mar 29;310(13):848–850. doi: 10.1056/NEJM198403293101310. [DOI] [PubMed] [Google Scholar]
Giugliano D., Torella R., Cacciapuoti F., Gentile S., Verza M., Varricchio M. Impairment of insulin secretion in man by nifedipine. Eur J Clin Pharmacol. 1980 Nov;18(5):395–398. doi: 10.1007/BF00636791. [DOI] [PubMed] [Google Scholar]
Milligan J. V., Kraicer J., Fawcett C. P., Illner P. Purified growth hormone releasing factor increases 45 Ca uptake into pituitary cells. Can J Physiol Pharmacol. 1972 Jun;50(6):613–617. doi: 10.1139/y72-091. [DOI] [PubMed] [Google Scholar]
Opie L. H. Drugs and the heart. III. Calcium antagonists. Lancet. 1980 Apr 12;1(8172):806–810. doi: 10.1016/s0140-6736(80)91303-3. [DOI] [PubMed] [Google Scholar]
Semple C. G., Thomson J. A., Beastall G. H., Lorimer A. R. Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function. Br J Clin Pharmacol. 1984 Feb;17(2):179–182. doi: 10.1111/j.1365-2125.1984.tb02336.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES